Form D · Pharmaceuticals
DemeRx, Inc.
Fort Lauderdale, FL · CIK 0001489594
Offering snapshot reported May 8, 2015 · SEC filing
- Reported sold
- $290K Offering amount: $500K
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Apr 14, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 8, 2015 | Initial | $289,569 | No comparison | 9 | SEC filing |
| Mar 1, 2013 | Amendment | $5,137,028 | $0vs Feb 27, 2013 | 35 | SEC filing |
| Feb 27, 2013 | Amendment | $5,137,028 | No comparison | 35 | SEC filing |
| Sep 4, 2012 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jun 21, 2010 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| May 3, 2010 | Initial | $85 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-239478
Source: Form D, filed May 8, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Skip Clemmons | Director |
| Lawrence Friedhoff, M.D., Ph.D., Facp | Director, Executive |
| Steve Gorlin | Director |
| Bruce Hack | Director |
| Maj. Gen. C. A. Hennies | Director |
| Charles Koob | Director |
| E. Douglas Kramer | Executive |
| Deborah Mash | Director, Executive |
| Deborah C. Mash, Ph.D. | Director, Executive |
| Henry Mellon | Director |
| Peter Nejes | Director |
| Steven M. Paul, M.D. | Director |
| Parker H. Petit | Director |
| Franklyn G. Prendergast, M.D., Ph.D. | Director |
| Jeffrey L. Raney | Executive |
| E. Burke Ross, Jr. | Director |
| Brian Thebault | Director |
| John C. Thomas, Jr. | Executive |
| Holger Weis | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
305 South Andrews Ave Suite 515
Fort Lauderdale, FL, 33301
Fort Lauderdale, FL, 33301